🇺🇸 FDA
Pipeline program

SNA02-48

PRO-SNA02-48-1001

Phase 2 mab active

Quick answer

SNA02-48 for Tetanus is a Phase 2 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Tetanus
Phase
Phase 2
Modality
mab
Status
active

Clinical trials